ICYMI: SKINNY LABELS, BIG SAVINGS ACT INTRODUCED IN U.S. HOUSE
Dec 9, 2025
Bipartisan Solution Would Help Bring More Generics and Biosimilars to Market,… Read More
© 2026 CSRXP- All Rights Reserved
Updates
CSRxP APPLAUDS U.S. HOUSE PASSAGE OF Q1/Q2 REFORMS TO FOSTER GREATER COMPETITION IN THE PRESCRIPTION DRUG MARKETPLACE
Dec 2, 2025
Bipartisan, Market-Based Solution Would Increase Transparency… Read More
DOSE OF REALITY: STUDY FURTHER HIGHLIGHTS THE COST OF BIG PHARMA’S BLOCKBUSTER BAILOUT
Nov 20, 2025
Analysis Finds Excluding Brand Name Drugs Approved to Treat Rare Diseases from… Read More
DOSE OF REALITY: JAMA NETWORK ANALYSIS SHINES LIGHT ON HOW BIG PHARMA PUSHES SALES OF HIGH-PRICED BLOCKBUSTERS BY TARGETING CONSUMERS ON SOCIAL MEDIA
Nov 19, 2025
Brand Name Drug Companies Sidestep Guardrails Meant to Protect American… Read More
ICYMI: I-MAK SURVEY FINDS FOUR IN FIVE AMERICANS SUPPORT PATENT REFORMS TO LOWER PRESCRIPTION DRUG PRICES
Nov 11, 2025
New Findings Underscore Broad-Based Support for Market-Based Solutions to Hold… Read More
BIG PHARMA EARNINGS WATCH: ASTRAZENECA
Nov 11, 2025
Major Drug Company Surpasses Wall Street Forecasts as Price Hikes Fuel Growth… Read More
BIG PHARMA EARNINGS WATCH: ABBVIE, AMGEN & PFIZER
Nov 6, 2025
Major Drug Companies Surpass Wall Street Forecasts as Price Hikes Boost… Read More
THEY SAID IT!: ADMINISTRATION HIGHLIGHTS HOW BIG PHARMA GAMES THE SYSTEM TO UNDERMINE BIOSIMILAR COMPETITION, KEEP PRESCRIPTION DRUG PRICES HIGH
Nov 6, 2025
HHS, FDA and CMS Leaders Emphasize How Streamlining Biosimilar Approvals Will… Read More
BIG PHARMA EARNINGS WATCH: GSK, MERCK, BRISTOL MYERS SQUIBB, ELI LILLY & GILEAD
Nov 3, 2025
Big Pharma Companies Beat Expectations After Hiking Prices on American… Read More
CSRxP APPLAUDS ADMINISTRATION FOR COMMITMENT TO FOSTERING GREATER BIOSIMILAR COMPETITION, LOWERING DRUG PRICES FOR AMERICAN PATIENTS
Oct 29, 2025
Efforts to Eliminate Red Tape and Boost Access to More Affordable Alternatives… Read More
CSRxP: HELP COMMITTEE SHOULD REJECT BIG PHARMA’S DEBUNKED INNOVATION RHETORIC, FOCUS ON IMPROVING COMPETITION TO HIGH-PRICED BIOLOGIC BLOCKBUSTERS
Oct 28, 2025
Lawmakers Can Add to Bipartisan Momentum for Market-Based Solutions to Foster… Read More
DOSE OF REALITY: NEW ICER REPORT FINDS BIG PHARMA CONTINUES SETTING INCREASINGLY OUT-OF-CONTROL LAUNCH PRICES UNJUSTIFIED BY CLINICAL VALUE
Oct 27, 2025
Launch Prices for 23 New Treatments Exceeding Estimates for a Fair Price Cost… Read More